EUVIMEDEUVIMED entdecken
Open Access

Pomegranate-derived nanovesicles as therapeutic agents for acute pancreatitis in a murine model: anti-inflammatory, antioxidant, and endocrine-protective properties

Isabel Torres-Cuevas, Christian M Sánchez-López, Antonio Marcilla, Salvador Pérez

Extracellular Vesicles and Circulating Nucleic Acids · 10.03.2026 · 7 (1) · 328-53

DOI: 10.20517/evcna.2025.145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 10.03.2026. Verfasst von Isabel Torres-Cuevas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Universitat de València, Valencia 46010, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Acute pancreatitis (AP) is an inflammatory disorder of the pancreas lacking specific therapy and frequently complicated by oxidative stress (OS) and long-term endocrine dysfunction, including pancreatogenic diabetes. Pomegranate-derived nanovesicles (PgNVs) contain bioactive lipids, proteins, and metabolites responsible for many health benefits of pomegranate juice. This study evaluated whether prophylactic PgNVs administration could mitigate pancreatic injury, OS, systemic inflammation, and subsequent endocrine impairment in a murine model of severe L-arginine-induced AP.

Methods

Male C57BL/6J mice were distributed to three groups: control, AP, and AP + PgNVs. A single subcutaneous dose of PgNVs (10 µg; ≈ 5 × 1010 particles) was administered 2 h before AP induction via intraperitoneal L-arginine. Animals were analyzed at 3, 7, 30, and 60 days post-induction. PgNVs were isolated using differential centrifugation, tangential-flow filtration, and size-exclusion chromatography.

Results

PgNVs pretreatment preserved pancreatic architecture, reduced edema, amylase activity, and interleukin 6 (IL-6) levels in both tissue and plasma by limiting nuclear factor-κB-p65 phosphorylation. PgNVs restored redox balance by upregulating NQO1 [NAD(P)H quinone dehydrogenase 1], improving oxidized glutathione (GSSG)/reduced glutathione (GSH) and homocystine/homocysteine ratios, and maintaining PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) expression. PgNVs protected β-cell mass, enhanced insulin secretion, and normalized glucose tolerance after AP. Proteomic profiling revealed that PgNVs changed extracellular vesicle composition, lowering pro-inflammatory markers [fibronectin, dipeptidyl peptidase-4 (DPP4)] and restoring anti-inflammatory ITIH4 (inter-alpha-trypsin inhibitor protein heavy chain 4).

Conclusion

PgNVs exert anti-inflammatory and antioxidant protection in experimental AP and preserve long-term endocrine function, highlighting their potential as a natural nanotherapeutic strategy to prevent pancreatic injury and post-pancreatitis diabetes.

Schlagwörter

Stichwörter der Autor:innen

Pomegranate-derived nanovesiclesacute pancreatitisendocrine dysfunctioninflammationoxidative stress

Autor:innen und Institutionen

  • Department of Physiology, Universitat de València, Valencia 46010, Spain.
  • Neonatal Research Group, Health Research Institute La Fe (IISLAFE), Valencia 46026, Spain.
  • These authors contributed equally to this work.
  • Parasites and Health Group, Àrea de Parasitologia, Departament de Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, Burjassot 46100, Spain.
  • Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, Health Research IIS La Fe-Universitat de València, Valencia 46026, Spain.

Zitieren

APA

Torres-Cuevas, I., Sánchez-López, C. M., Marcilla, A., & Pérez, S. (2026). Pomegranate-derived nanovesicles as therapeutic agents for acute pancreatitis in a murine model: anti-inflammatory, antioxidant, and endocrine-protective properties. Extracellular Vesicles and Circulating Nucleic Acids, 7(1), 328-53. https://doi.org/10.20517/evcna.2025.145

Vancouver

Torres-Cuevas I, Sánchez-López CM, Marcilla A, Pérez S. Pomegranate-derived nanovesicles as therapeutic agents for acute pancreatitis in a murine model: anti-inflammatory, antioxidant, and endocrine-protective properties. Extracellular Vesicles and Circulating Nucleic Acids. 2026;7(1):328-53. doi:10.20517/evcna.2025.145

BibTeX
@article{TorresCuevas2026,
  author = {Torres-Cuevas, Isabel and Sánchez-López, Christian M and Marcilla, Antonio and Pérez, Salvador},
  title = {Pomegranate-derived nanovesicles as therapeutic agents for acute pancreatitis in a murine model: anti-inflammatory, antioxidant, and endocrine-protective properties},
  journal = {Extracellular Vesicles and Circulating Nucleic Acids},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {328--53},
  doi = {10.20517/evcna.2025.145}
}
Kostenlos starten →